![]() |
产地 | 上海 |
品牌 | OminimAbs |
保存条件 | |
货号 | OM641708 |
用途 | 实验研究 |
应用范围 | 科研实验 |
抗原来源 | 电询 |
保质期 | 2年 |
抗体名 | 电询 |
是否单克隆 | 否 |
克隆性 | 否 |
靶点 | 电询 |
适应物种 | 电询 |
形态 | 电询 |
宿主 | 电询 |
标记物 | 电询 |
包装规格 | 毫升 |
亚型 | 电询 |
标识物 | 电询 |
浓度 | 电询% |
免疫原 | 电询 |
是否进口 | 否 |
Product Profile
Product Name
Anti-VEGFA antibody
Antibody Type
Primary Antibodies
Immunogen
Polypeptide
Key Feature
Clonality
Polyclonal
Isotype
IgG
Host Species
Rabbit
Tested
Application
ELISAICC/IFIHCWB
WB:1:200-1:2000
Species
Reactivity
HumanMouseRat
Concentration
1 mg/ml
Purification
Protein A
Target Information
Gene Symbol
VEGFA
Gene Synonyms
VPF
Gene Full Name
vascular endothelial growth factor A
Gene Summary
This gene is a member of the PDGF/VEGF
growth factor family. It encodes a heparin-binding protein, which exists as a
disulfide-linked homodimer. This growth factor induces proliferation and
migration of vascular endothelial cells, and is essential for both
physiological and pathological angiogenesis. Disruption of this gene in mice
resulted in abnormal embryonic blood vessel formation. This gene is
upregulated in many known tumors and its expression is correlated with tumor
stage and progression. Elevated levels of this protein are found in patients
with POEMS syndrome, also known as Crow-Fukase syndrome. Allelic variants of
this gene have been associated with microvascular complications of diabetes 1
(MVCD1) and atherosclerosis. Alternatively spliced transcript variants
encoding different isoforms have been described. There is also evidence for
alternative translation initiation from upstream non-AUG (CUG) codons
resulting in additional isoforms. A recent study showed that a C-terminally
extended isoform is produced by use of an alternative in-frame translation
termination codon via a stop codon readthrough mechanism, and that this
isoform is antiangiogenic. Expression of some isoforms derived from the AUG start
codon is regulated by a small upstream open reading frame, which is located
within an internal ribosome entry site. The levels of VEGF are increased
during infection with severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2), thus promoting inflammation by facilitating recruitment of
inflammatory cells, and by increasing the level of angiopoietin II (Ang II),
one of two products of the SARS-CoV-2 binding target, angiotensin-converting
enzyme 2 (ACE2). In turn, Ang II facilitates the elevation of VEGF, thus
forming a vicious cycle in the release of inflammatory cytokines. [provided
by RefSeq, Jun 2020]
Hide
Molecular
Weight(MW)
27 kDa(Observed:40
kDa)
Source
Rabbit
Cellular
Localizatio
Secreted
Application
IHC:1:200-1:1000
ICC/IF:1:100-1:500
VEGF
MVCD1
·
WB
Western blot analysis using VEGFA antibody against PANC-1 (1), Jurkat (2) cell lysate.
·
IHC
Immunohistochemical analysis of paraffin-embedded thyroid carcinoma tissues using VEGFA antibody with DAB staining.
·
ICC/IF
Immunofluorescence analysis of Hela cells using VEGFA antibody (green). Blue: DAPI fluorescent DNA dye. Red: Actin filaments have been labeled with Alexa Fluor- 555 phalloidin.
Application Notes |
WB:1:200-1:2000 |
Additional Information
Form |
Liquid |
Storage Instruction |
Shipped at 4°C. Store at +4°C short term (1-2 weeks). Store at -20°C long term. Avoid freeze / thaw cycle. |
Storage Buffer |
Purified antibody in PBS with 0.05% sodium azide. |